In-vivo electrophysiology has identified neurons that are selectively active in waking, NREM, or REM sleep (for review see Shiromani and Peever, 2017). However, this method has limitations. New tools are needed to disentangle the brain circuitry regulating complex behaviors such as sleep. We use deep-brain imaging to measure calcium (Ca2+) gradients associated with excitatory signaling (Tian et al., 2009) (Ghosh et al., 2011) in neurons that contain the vesicular GABA transporter (vGAT). The vGAT neurons are a distinct population juxtapositioned with the neurons that contain orexin or MCH in the lateral hypothalamus (BlancoCenturion et al., 2018), but their activity in sleep in freely-behaving animals is unknown. Methods: In vGAT-cre mice, rAAV-DIO-GCaMP6m was delivered stereotaxically to the lateral hypothalamus (isofluorane anesthesia) and a GRIN lens and sleep electrodes were implanted. Three weeks later a miniscope (nVista; Inscopix.com) revealed single vGAT neurons. Results: Thirty-eight vGAT neurons were automatically extracted (PCA-ICA analysis; Mosaic software) from three vGAT-cre mice (female). The average fluorescence was significantly higher during both active wake and REM sleep compared to QW, NREM or REM transition [F(4,175) 
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Introduction: Recent data implicate abnormalities of the thalamic reticular nucleus (TRN) and thalamocortical circuitry in schizophrenia (SZ) risk. Sleep spindles are initiated by the TRN and propagated to the cortex via thalamocortical feedback loops. During wakefulness, TRN modulates sensory processing by gating thalamocortical communication. Patients with SZ and their first-degree relatives (familial-high-risk,FHR) exhibit sleep spindle and sensory gating deficits. In two studies, we investigated the two SZ biomarkers in relation to thalamocortical connectivity in chronic and early-course psychotic disorders and FHR. Methods: Twenty-six SZ and 29 healthy controls (HC) participated in Study1; 10 early-course patients with psychotic disorders (PSY), 14 FHR and 16 HC participated in Study2. All participants completed a resting-state fMRI session and thalamocortical seedto-voxel connectivity was computed. In a separate session, nocturnal sleep was monitored with PSG for Study1. Sleep spindles were identified using an automated wavelet detector. Study2 included a sensory gating event-related-potentials (ERP) experiment. Gating was calculated as the suppression of the auditory P50 for the second of a pair of identical clicks. Whole brain regression analyses were used to examine relations of thalamocortical connectivity with spindles and sensory gating (we report p FDR ≤.05). Results: SZ showed widespread reductions in spindle density (38 electrodes, p corrected =.009). Reduced spindle density was associated with significantly greater thalamic connectivity with left sensory-motor cortex (MNI:x=-24,y=-16,z=64; BA4; no slope difference) in regions that overlap with those SZ patients show abnormal thalamocortical hyperconnectivity. Relative to HC, PSY exhibited marginally-reduced sensory gating (t(19)=-1.9, p=.07; FHR vs HC non-significant). Reduced sensory gating correlated with weaker thalamocortical connectivity in the right dorsolateral-prefrontal-cortex (DLPFC; [44,44,-2] ; BA46; no slope difference) connectivity in this cluster was significantly reduced in PSY vs. HC (t(19)= 2.2, p=.04; FHR vs HC non-significant).
Conclusion:
In two experiments, we show that two SZ biomarkers, sleep spindle and sensory gating deficits are associated with abnormal thalamocortical connectivity, suggesting that they arise from a common mechanism. Data collection for Study2 is ongoing and increased sample sizes will allow for analysis of the specificity of these abnormalities to SZ and SZ risk. Support (If Any): K01MH114012 group had a documented injury within the past 12 months. Daytime sleepiness was assessed using the Epworth Sleepiness Scale (ESS), while functional connectivity was measured using resting-state functional magnetic resonance imaging. A seed-to-voxel analysis, using bilateral thalamic seed regions, was conducted in the CONN toolbox to identify differences in the association between thalamocortical connectivity and ESS between the two groups. Introduction: Obstructive Sleep Apnea (OSA) is a prevalent condition and a major cause of morbidity and mortality. OSA contributes to the development and progression of neurocognitive, metabolic, cardiovascular, and oncologic diseases. The tongue and specifically genioglossus (GG) muscle have been implicated in the pathogenesis of upper airway (UA) obstruction during sleep. Nasal positive airway pressure can treat OSA but poor adherence severely limits its effectiveness. We have previously shown that obese C57BL/6J mice have OSA, similar to humans. We have also shown that DREADDs deployed by intracerebral injection in the XII nucleus and activated with specific ligand clozapine-N-oxide (CNO) increases UA patency in mice. Several challenges preclude the translational use of our previous approach including (a) intracerebral injections; (b) CNO conversion psychotropic active clozapine. We hypothesized that, in mice, UA patency can be improved and sleep apnea can be treated by injecting DREADD carried by an adeno-associated virus type 9 (AAV9) capable of retrograde neuronal transport and activated by a novel ligand JHU37160 (J60). Methods: Excitatory DREADD (AAV9-hSyn-hM3(Gq)-mCherry n=10) or Control AAV9-hSyn-GFP (n=5) was delivered bilaterally by tongue injection to mice with diet induced obesity. Six weeks after the delivery, mice were injected with J60 or saline intraperitoneally (IP) using a cross-over design and submitted to GG electromyography (EMGGG), UA dynamic MRI and sleep studies. Results: In all mice 15 mice DREADDs or control virus were expressed in the hypoglossal nucleus confirming effective retrograde transport after the GG injection. DREADDs transfected mice showed a striking 7.05 fold increase in tonic EMG GG activity and nearly 2 fold increase in EMG GG activity after J60 injection (p<0.001). In MR imaging, axial dynamic images demonstrated significant pharyngeal dilation At the rim of the soft palate upon the ligand administration (0.46 ± 0.03mm 2 to 1.16±0.05mm 2 , p<0.05). Sleep studies currently in progress. Conclusion: Lingual muscles can be successfully stimulated using retrograde transgenic approach to activate motor neuron groups in selected brain areas. Our results suggest that retrograde delivery of DREADD to the hypoglossal nucleus effectively controls pharyngeal patency and may treat OSA Support (If Any): R01HL138932-0 and ATS Unrestricted Grant. Introduction: Endotoxemia is characterized by the sleep impairment and marked changes in thermoregulation and other physiological functions. The heat shock proteins 70 kDa (Hsp70) were shown to possess protective effects against numerous stress factors, including endotoxemia, in both in vitro and in vivo experiments. The purpose of the present study was to examine the effects of exogenous Hsp70/Hsc70 on sleep and thermoregulatory characteristics in rat endotoxemia model. Methods: Male Wistar rats were implanted with electrodes for polysomnography and thermistor to measure brain temperature. The endotoxemia model was established by the intravenous injection of lipopolysaccharide (LPS). Exogenous Hsp70/Hsc70 (purified and consisting of constitutive and inducible isoforms) was injected 15 min before LPS. In control experiments, animals received the intravenous injections of vehicle (saline). Recordings were performed for 24 hours using the SASR 8800 system. Results: The injections of LPS evoked the increase in total time of slow-wave sleep (SWS) within 2-5 hours (due to the increase in number of its episodes) and the decrease in total time of wakefulness and rapid-eye-movement sleep (REM). The rise in brain temperature and contractile muscular activity (CMA) were observed within 2-7 and 1-5 hours respectively. The pre-treatment of animals by Hsp70/Hsc70 caused the restoration of total time of SWS and wakefulness an hour earlier and the recovery of total time of REM 2 hours earlier in comparison with LPS alone. Although the total amount of SWS remained high, its structure was changed due to the increase in episode duration and SWS become less fragmented. Furthermore, Hsp70/Hsc70 injection led to the attenuation of febrile rise in brain temperature and CMA and to restoration of these parameters 3 and 2 hours earlier, respectively. Conclusion: The pre-treatment by Hsp70/Hsc70 can hasten the restoration of temporal characteristics of sleep and wakefulness, evoke the elongation of SWS episodes and reduce the rise in brain
